Opsoclonus-myoclonus syndrome associated with multiple system atrophy
© Shindo et al.; licensee BioMed Central Ltd. 2014
Received: 5 August 2014
Accepted: 29 August 2014
Published: 1 November 2014
Opsoclonus-myoclonus syndrome (OMS) is well known as a paraneoplastic syndrome or as a parainfectious neurologic complication. However, OMS associated with a neurodegenerative disorder has not been described previously. A 48-year-old woman had been diagnosed as multiple system atrophy-parkinsonian type (MSA-P) based on the findings of dopamine non-responsive parkinsonism with autonomic failure and typical findings on magnetic resonance imaging 5 years ago. She exhibited recurrent asynchronous and arrhythmic myoclonic movements of the upper limbs and abdomen with a very short duration, and involuntary eye movements, which were repetitive, rapid, random, multidirectional, conjugate saccades of irregular amplitude and frequency at rest. Based on hematological and radiological findings, the diagnosis was advanced MSA-P associated with OMS. As far as we are aware, there have not been any previous reports of such a case.
KeywordsOpsoclonus-myoclonus syndrome Multiple system atrophy Ocular symptom Cerebellar vermis Pontine reticular formation
Opsoclonus-myoclonus syndrome (OMS) is well known as a paraneoplastic syndrome, especially in children with neuroblastoma, or as a parainfectious neurologic complication of diseases such as HIV infection –. In previous reports, other causes that have been documented include multiple sclerosis, cerebrovascular disease, sarcoidosis, pregnancy, autoimmune disorders, and adverse reactions to several drugs. However, OMS associated with a neurodegenerative disorder has not been described previously ,,–. Here we report a patient with advanced multiple system atrophy-parkinsonian type (MSA-P) who developed OMS. As far as we are aware, there have not been any previous reports of such a case.
A 48-year-old woman had presented 7 years ago with left hand tremor, gait disturbance related to bradykinesia of all four limbs, and postural instability. Decreased sweating during summer and recurrent syncope after standing due to an excessive fall of blood pressure had been noted 5 years ago, and MSA-P had been diagnosed based on the findings of dopamine non-responsive parkinsonism combined with autonomic failure and abnormal linear signal intensities in the putamen bilaterally on magnetic resonance imaging. Her bradykinesia and rigidity gradually increased, resulting in inability to walk and stand unassisted, while oral intake became impaired by dysphagia due to pseudobulbar palsy 1 year ago. In April 2012, she was admitted to our hospital because of frequent episodes of dizziness even in the supine position and transient episodes of involuntary twitching of her upper limbs for 3 months. There was a history of hyperthyroidism when she was 41 years old, which had been treated and was well controlled. Her family history was unremarkable.
On admission, supine blood pressure was 136/74 mmHg and it decreased to 82/46 mmHg with head-up tilt of 45 degrees. Neurological examination revealed mild dementia, a very small voice, severe dysphagia, moderate rigidity of the neck and all limbs, severe bradykinesia, exaggerated deep tendon reflexes, positive pathological reflexes in the lower limbs, diffuse muscle atrophy due to disuse, and autonomic symptoms/signs such as systemic anhydrosis, orthostatic hypotension, constipation, and dysuria. She exhibited recurrent asynchronous and arrhythmic myoclonic movements of the upper limbs and abdomen with a very short duration, which occurred at rest and were also induced by sudden sound, touch or painful stimuli. Very mild cerebellar ataxia was found in her upper limbs, but palatal tremor was not present. Ophthalmic examination (Additional file 1) demonstrated involuntary eye movements, which were repetitive, rapid, random, multidirectional, conjugate saccades of irregular amplitude and frequency at rest. These movements continued whether her eyes were open or closed and became more exaggerated when she attempted to follow the finger of an examiner.
Based on these findings, the diagnosis was advanced MSA-P associated with OMS. Treatment of her involuntary movements was performed with clonazepam, valproic acid, gabapentin, levetiracetam, trihexyphenidyl, levodopa, and baclofen. Although subjective dizziness at rest and jerky limbs myoclonus almost resolved, a mild degree of opsoclonus persisted as of July 2014.
In adults, OMS typically presents as a paraneoplastic syndrome that is usually related to lung cancer or other malignancies –. Our patient showed no elevation of tumor markers and was negative for paraneoplastic antibodies. CT of the thorax and breasts was also unremarkable, although endoscopic evaluation of the gastrointestinal tract was not performed due to severe akinesia and dysphagia. Moreover, opsoclonus still persisted at two years after the onset of OMS, while nothing suggestive of malignancies was found by physical examination and imaging studies. Thus, paraneoplastic syndrome was considered to be excluded as a differential diagnosis. Other possible etiologies, such as parainfectious syndrome, direct infection of the brain, cerebrovascular disease, and autoimmune disease were excluded from the clinical course, antibody studies, normal CSF findings, and brain MRI findings. We therefore considered that this patient had OMS accompanied by advanced MSA.
Patients with MSA have been reported to show various ocular symptoms such as saccadic pursuit, blurred vision, nystagmus, anisocoria, Horner’s syndrome, facial dystonia, and limitation of upward gaze, downward gaze, and horizontal gaze ,. However, opsoclonus has not been previously reported in a patient with MSA or in other parkinsonian syndromes. On the other hand, jerky tremor or distal myoclonus, with an irregular myoclonic postural or action tremor of the distal limbs, has been reported in 3 ~ 31% of MSA patients and it is one of the features supporting diagnosis of this disease –.
Although the pathophysiological mechanism of OMS remains unclear, lesions of two neuroanatomical structures have been suggested to be responsible based on histological and biochemical studies. One possibility is a cerebellar lesion interrupting normal vermian inhibition of the fastigial nucleus, which regulates vestibular nuclear tone to burst neurons –. The other possibility is a lesion of the caudal pontine reticular formation affecting the function of pause neurons that inhibit the burst neurons that drive saccades ,,. It is also speculated that reticular formation lesions could lead to hyperexcitability of burst neurons. Cerebellar lesions involving the vermis and pontine lesions affecting the reticular formation have often been demonstrated by previous neuropathological studies ,, so opsoclonus might be expected in patients with MSA. It is speculated that opsoclonus was observed in the present case due to lesions of the brainstem and basal ganglia along with comparative preservation of cerebellar function based on the physical and radiological findings up to the advanced stage, because cerebellar hyperperfusion or activation has been detected by SPECT or fMRI in previous investigations of OMS as a paraneoplastic syndrome ,,.
Since opsoclonus is a characteristic feature in ocular involuntary movements, detection of opsoclonus in addition to jerky myoclonic tremor might be useful as one of the supporting features for diagnosis of MSA. To conclude the causative relationship between OMS and MSA, statistical analysis of the frequency of opsoclonus in a large population of MSA patients may be important.
Opsoclonus-myoclonus syndrome associated with a neurodegenerative disorder has not been described previously. In a 48-year-old woman diagnosed as multiple system atrophy, recurrent arrhythmic myoclonic movements of the upper limbs and abdomen, and involuntary eye movements, which were repetitive, rapid, random, multidirectional, conjugate saccades of irregular amplitude and frequency were observed at rest. Based on hematological and radiological findings, the diagnosis was advanced multiple system atrophy associated with opsoclonus-myoclonus syndrome. As far as we are aware, there have not been any previous reports of such a case.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by Editor-in-Chief of this journal.
Multiple system atrophy
- Sotirchos ES, Dorsey ER, Tan IL, Zee DS: Opsoclonus-myoclonus syndrome and exaggerated startle response associated with small-cell lung cancer. Mov Disord 2011, 26: 1769–70. 10.1002/mds.23627PubMedView ArticleGoogle Scholar
- Wong AMF, Musallam S, Tomlinson RD, Shannon P, Sharpe JA: Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates. J Neurol Sci 2001, 189: 71–81. 10.1016/S0022-510X(01)00564-0PubMedView ArticleGoogle Scholar
- Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit A, Bartleson JD, Kumar R, McEvoy KF, McKeon A: Adult- onset opsoclonus-myoclonus syndrome. Arch Neurol 2012, 69: 1598–607. 10.1001/archneurol.2012.1173PubMedView ArticleGoogle Scholar
- Van Toorn R, Rabie H, Warwick JM: Opsoclonus-myoclonus in an HIV-infected child on antiretroviral therapy-possible immune reconstitution inflammatory syndrome. Eur J Pediatr Neurol 2005, 9: 423–6. 10.1016/j.ejpn.2005.06.007View ArticleGoogle Scholar
- Hattori T, Hirayama K, Imai T, Yamada T, Kojima S: Pontine lesion in opsoclonus-myoclonus syndrome shown by MRI. J Neurol Neurosurg Psychiatry 1988, 51: 1572–75. 10.1136/jnnp.51.12.1572PubMed CentralPubMedView ArticleGoogle Scholar
- Baets J, Pals P, Bergmans B, Foncke E, Smets K, Hauman H, Vanderwegen L, Cras P: Opsoclonus-myoclonus syndrome: a clinicopathological confrontation. Acta Neurol Belg 2006, 106: 142–6.PubMedGoogle Scholar
- Boland T, Strause J, Hu M, Santamaria D, Liang TW, Kremens D, Sergott R, Moussouttas M: Posterior reversible encephalopathy syndrome presenting as opsoclonus-myoclonus. Neuro-Ophthalmology 2012, 36: 149–52. 10.3109/01658107.2012.667186PubMed CentralPubMedView ArticleGoogle Scholar
- Wenning GK, Shlomo B, Magalhaes M, Daniel SE, Quinn NP: Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994, 117: 835–45. 10.1093/brain/117.4.835PubMedView ArticleGoogle Scholar
- Wenning GK, Tison F, Shlomo B, Daniel SE, Quinn NP: Multiple system atrophy: A review of 203 pathologically proven cases. Mov Disord 1997, 12: 133–47. 10.1002/mds.870120203PubMedView ArticleGoogle Scholar
- Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Dürr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M: Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71: 670–6. 10.1212/01.wnl.0000324625.00404.15PubMed CentralPubMedView ArticleGoogle Scholar
- Kume A, Takahashi A, Hashizume Y, Asai J: A histometrical and comparative study on Purkinje cell loss and olivary nucleus cell loss in multiple system atrophy. J Neurol Sci 1991, 101: 178–86. 10.1016/0022-510X(91)90043-7PubMedView ArticleGoogle Scholar
- Braak H, Rub U, Del Tredici K: Involvement of precerebellar nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 2003, 29: 60–76. 10.1046/j.1365-2990.2003.00432.xPubMedView ArticleGoogle Scholar
- Oguro K, Kobayashi J, Aiba H, Hojo H: Opsoclonus-myoclonus syndrome with abnormal single photon emission computed tomography imaging. Pediatr Neurol 1997, 16: 334–6. 10.1016/S0887-8994(97)00031-3PubMedView ArticleGoogle Scholar
- Helmchen C, Rambold H, Sprenger A, Erdmann C, Binkofski F: Cerebellar activation in opsoclonus. An fMRI study. Neurology 2003, 61: 412–5. 10.1212/01.WNL.0000073271.66866.51PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.